Molecular genetic indicators of the probability of early myocardial systolic dysfunction signs in doxorubicin chemotherapy in patients with breast cancer of moderate and low HFA-ICOS risk groups

Molecular genetic indicators of the probability of early myocardial systolic dysfunction signs in doxorubicin chemotherapy in patients with breast cancer of moderate and low HFA-ICOS risk groups

Aim. To study the association of rs2232228 (HAS3 gene), rs2229774 (RARG gene), rs1056892 (CBR3 gene), rs1786814 (CELF4 gene), rs1695 (GSTP1 gene), rs8187710 (ABCC2 gene), rs7853758 (SLC28A3 gene), rs243865 (MMP­2 gene), rs243866 (MMP­2 gene), rs35068180 (MMP­3 gene), rs522616 (MMP­3 gene), rs679620...

Full description

Saved in:
Bibliographic Details
Main Authors: I. A. Karput, V. A. Snezhitsky, M. N. Kurbat, O. A. Gorustovich, A. V. Kopytsky, A. S. Babenko
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2024-11-01
Series:Российский кардиологический журнал
Subjects:
doxorubicin
global longitudinal myocardial strain
breast cancer
cardiotoxicity
dilated cardiomyopathy
genes
polymorphism
allelic variant
Online Access:https://russjcardiol.elpub.ru/jour/article/view/5993
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://russjcardiol.elpub.ru/jour/article/view/5993

Similar Items